rdf:type |
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0032893,
umls-concept:C0087111,
umls-concept:C0332307,
umls-concept:C0442027,
umls-concept:C0814225,
umls-concept:C0907402,
umls-concept:C0935929,
umls-concept:C1518527,
umls-concept:C2587213
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-1-3
|
pubmed:abstractText |
This observational study aimed to investigate the long-term efficacy and safety of adding insulin glargine (LANTUS((R))) to support oral antidiabetic (OAD) treatment in patients with type 2 diabetes in everyday practice.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1462-8902
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17199716-Administration, Oral,
pubmed-meshheading:17199716-Aged,
pubmed-meshheading:17199716-Blood Glucose,
pubmed-meshheading:17199716-Body Mass Index,
pubmed-meshheading:17199716-Diabetes Mellitus, Type 2,
pubmed-meshheading:17199716-Drug Therapy, Combination,
pubmed-meshheading:17199716-Female,
pubmed-meshheading:17199716-Follow-Up Studies,
pubmed-meshheading:17199716-Hemoglobin A, Glycosylated,
pubmed-meshheading:17199716-Humans,
pubmed-meshheading:17199716-Hypoglycemic Agents,
pubmed-meshheading:17199716-Insulin,
pubmed-meshheading:17199716-Insulin, Long-Acting,
pubmed-meshheading:17199716-Male,
pubmed-meshheading:17199716-Middle Aged,
pubmed-meshheading:17199716-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients.
|
pubmed:affiliation |
Diabetologe DDG, Quickborn, Germany. stephan.schreiber@diabetes-hamburg.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|